Julia Spiess Lewis
Perry Communications Group
Bonnie J. Addario Lung Cancer Foundation Launches First Ever Simplified Chinese Resources to Help Patients Navigate Care, Diagnosis and Treatment
ALCF releases simplified Chinese version of Patient Handbook for Asian communities
SAN CARLOS, Calif. (September 10, 2015) — Today, the Bonnie J. Addario Lung Cancer Foundation (ALCF) released a simplified Chinese language version of its patient handbook, “Navigating Lung Cancer, 360 Degrees of Hope,” to provide critical information and resources for Asian lung cancer patients and caregivers across the world.
“There is a huge void of resources for Asians with lung cancer,” said Bonnie J. Addario, 10-year lung cancer survivor and founder of the ALCF. “Being diagnosed with cancer is scary enough, but not knowing what resources are available to educate yourself makes good health-care decision making impossible. By removing this language barrier, we are helping them to receive the care they need.”
Lung cancer is the number one cause of cancer deaths in Asians, but 40 percent of those diagnosed have never smoked, according to the American Cancer Society.*
“As the presenting sponsor, Boehringer Ingelheim is proud to support the ALCF’s pioneering initiative to reach the Asian community with tailored educational resources,” said Kevin Lokay, vice president and business unit head of oncology, Boehringer Ingelheim Pharmaceuticals, Inc. “Half of Asians with lung cancer have a specific kind of cancer mutation, which may impact their future prognosis and treatment, yet many have little awareness about lung cancer diagnosis, molecular testing and treatment options. Through this initiative and several others in the Asian community, we are working to increase understanding of lung cancer in Asians so that we can help everyone fight this devastating disease.”
The ALCF’s patient handbook is a first-of-its-kind, comprehensive, up-to-date patient resource for lung cancer patients and their families. First released in English in early 2013, the handbook contains the latest advancements in lung cancer care, including new FDA approved drugs, molecular testing, immunotherapy and a special clinical trials report. The resource is now available in Spanish and simplified Chinese, online and in print.
“Translating the manual into simplified Chinese is a great boon to Chinese lung cancer patients,” said David Jablons, M.D., FACS, Professor and Chief of the Section of General Thoracic Surgery at UCSF, and Program Leader of Thoracic Oncology. “China is the epicenter of a mushrooming lung cancer crisis and remains the dominant health care problem in China. The manual will be a welcomed adjunct to the soon-to-be millions of lung cancer patients in China and yet again confirms the ALCF’s global commitment to patient advocacy. An informed patient is an empowered patient. This manual will undoubtedly be an important tool for Chinese patients, families and physicians alike all united by the great struggle against lung cancer.”
*American Cancer Society. Cancer Facts and Figures 2014. Atlanta: American Cancer Society; 2014 Toh C K, Gao F, Lim W T. et al Never-smokers with lung cancer; epidemiological evidence of a distinct disease entity. J Clin Oncol 2006. 242245-2251,2251
About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education, and treatment. The Foundation’s goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised more than $20 million for lung cancer research and related programs.